Results 131 to 140 of about 10,059 (251)

Impact of Candida species colonization and azoles resistance in a neonatal intensive care unit [PDF]

, 2017
Background: Candida species are among the top 10 most frequently isolated nosocomial bloodstream pathogens in Europe. In particular, in neonatal intensive care units (NICUs) Candida infections are an emerging concern because of the increasing incidence ...
Corsello, G., Geraci, D., Giuffre, M., Graziano, G., Insinga, V., Maida, C., Saporito, L., Torregrossa, M., Vecchio, D., Vitale, F.   +9 more
core  

Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults [PDF]

, 2009
Jared L. Crandon, Mary Anné Banevicius, Annie Fang, Penelope Crownover, R. Fredrick Knauft, J. Samuel Pope, John Russomanno, Eric Shore, David P. Nicolau, Joseph L. Kuti   +9 more
openalex   +1 more source

FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy [PDF]

, 2010
Sofia Costa‐de‐Oliveira, Isabel M. Miranda, Raquel M. Silva, Ana P. Silva, Rita Rocha, António Amorim, Acácio G. Rodrigues, Cidália Pina‐Vaz   +7 more
openalex   +1 more source

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration [PDF]

, 2011
Judith Leitner, B Meyer, Valentin Fuhrmann, K. Saria, C. Zuba, Walter Jäger, Michaela Böhmdorfer, Florian Thalhammer   +7 more
openalex   +1 more source

Treatment options of invasive fungal infections in adults. [PDF]

, 2006
A panel of infectious disease specialists, clinical microbiologists and hospital epidemiologists of the five Swiss university hospitals reviewed the current literature on the treatment of invasive fungal infections in adults and formulated guidelines for
Bille, J, Calandra, T, Eggimann, P, Flückiger, U, Fungal, Infection Network of Switzerland (FUNGINOS), Garbino, J, Glauser, M, Imhof, A, Marchetti, O, Pittet, D, Ruef, C, Täuber, M, Zimmerli, S   +12 more
core  

In Vitro Pharmacodynamics of Anidulafungin and Caspofungin against Candida glabrata Isolates, Including Strains with Decreased Caspofungin Susceptibility

, 2006
Jason M. Cota, Michael Carden, John R. Graybill, Laura K. Najvar, David S. Burgess, Nathan P. Wiederhold   +5 more
openalex   +1 more source

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis [PDF]

, 2011
Chin Fen Neoh, Danny Liew, Monica A. Slavin, D. Marriott, S. C.- A. Chen, Orla Morrissey, K. Stewart, David C. M. Kong   +7 more
openalex   +1 more source

Anidulafungin Pharmacokinetics and Microbial Response in Neutropenic Mice with Disseminated Candidiasis

, 2006
Tawanda Gumbo, George L. Drusano, Weiguo Liu, Lei Ma, Mark R. Deziel, Michael F. Drusano, Arnold Louie   +6 more
openalex   +1 more source

In Vitro Activity of Anidulafungin against Candida albicans Biofilms

, 2008
Melissa Jacobson, Kerryl E. Piper, Gary Nguyen, James M. Steckelberg, Robin Patel   +4 more
openalex   +1 more source

In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs [PDF]

, 2012
Maria Drogari‐Apiranthitou, F.-D. Mantopoulou, Anna Skiada, Lamprini Kanioura, M. Grammatikou, Georgia Vrioni, A. Mitroussia-Ziouva, Athanassios Tsakris, G. Petrikkos   +8 more
openalex   +1 more source